Investor Presentaiton slide image

Investor Presentaiton

ANDA¹ Portfolio & Pipeline (As on 31st Dec 2019) Total 170 + 22 + 65 ANDA Portfolio 29 56 9 76 76 3 11 Approved ANDAS Tentatively Approved ANDAS ■Cipla Ltd Cipla-PEPFAR2 ■Invagen 1 Does not include Vet product ANDAS 2 PEPFAR approved ANDAS can be commercialised in US Investor Presentation: Q3FY20 Partnered ANDAS 22 3 36 Under Approval ANDAS Cipla 257 ANDAS 10
View entire presentation